Poteligeo Coupon & Prices

Your monthly Poteligeo cost savings if eligible

If you are eligible for the Poteligeo patient assistance program, the cost of your medication will be free. We only charge $49 per month for each medication, to cover our service fees. You could receive your Poteligeo prescription for just $49 a month, regardless of the retail price of your medication.

Am I eligible for the Poteligeo patient assistance program?

We will review your application to determine whether you are eligible for the Poteligeo patient assistance program. Each program has its own eligibility criteria which are set by the pharmaceutical companies, however, the factors considered by most programs are:

• I am a permanent, legal resident of the United States or Puerto Rico
• I am uninsured or my insurance doesn’t cover my medication
• I meet certain income eligibility requirements

How do I apply for the Poteligeo patient assistance program?

We make it as easy as possible to apply for the Poteligeo patient assistance program. The first step is to complete our enrollment application. Tell us about any medications you are taking, including Poteligeo. We will also ask for details about your healthcare provider, insurance, and your household income. This information is required by the pharmaceutical manufacturers who ship your medication.

If we determine that you may be eligible for Poteligeo assistance, we will handle the application process for you. We will work directly with your healthcare provider to prepare your application documents. Once we have received the signed application and supporting documents, we will submit them to the patient assistance program on your behalf. Our service continues once you are enrolled in the Poteligeo patient assistance program, and we will automatically request your Poteligeo medication refills for up to 1 year.

Is NiceRx a Poteligeo coupons provider?

We are a service provider that helps eligible individuals access the Poteligeo patient assistance program. That means that we do not offer printable Poteligeo manufacturer coupons, Poteligeo discounts, or free Poteligeo samples. We are not a Poteligeo coupon provider or Poteligeo discount card. Our service extends to assisting eligible individuals to access the medications they need through patient assistance programs.

Can NiceRx help me get Poteligeo if I have insurance?

We may be able to help you to access Poteligeo patient assistance in a variety of circumstances. This includes when your insurance company will not pay for your Poteligeo medication or if you have a high copay or coinsurance responsibility. We may also be able to help you if you do not have insurance. Please apply online to find out more.

How much does Poteligeo cost without insurance?

Poteligeo cost without insurance will vary depending on where you buy it. As a guide, Poteligeo intravenous solution (4 mg/mL) usually costs $4,200 for 5 milliliters. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.

How much does Poteligeo cost with insurance?

The copay for Poteligeo with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.

What is Poteligeo?

Poteligeo is an FDA (U.S. Food and Drug Administration) approved marketed by Kyowa Kirin, Inc. Poteligeo is a CC chemokine receptor type 4 (CCR4)- directed monoclonal antibody used for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.

Mycosis fungoides and Sézary syndrome are rare diseases and are hard-to-treat types of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin lymphoma, in which lymphocytes (white blood cells) become cancerous and affect the skin. Poteligeo is more effective than vorinostat, for the treatment of either mycosis fungoides or Sezary syndrome.

What doses of Poteligeo are available?

Poteligeo is available in injection form, in the following doses: 20 mg/5 mL (4 mg/mL) solution in a single-dose vial.

The recommended dosage is 1 mg/kg as an intravenous infusion over at least 60 minutes on days 1, 8, 15, and 22 of the first 28-day cycle and on days 1 and 15 of each subsequent cycle.

Always speak with a healthcare professional for medical advice or about any changes to your dose so they can monitor and evaluate your condition.

Poteligeo active ingredients

Poteligeo contains the active ingredient mogamulizumab-kpkc. Poteligeo works against CC chemokine receptor 4 (CCR4), a G-protein coupled receptor that is overexpressed in the malignant cells of various blood cancers.

Poteligeo side effects

The most common side effects of Poteligeo in clinical trials include:

• Rash
• Infusion-related reactions
• Fatigue
• Diarrhea
• Musculoskeletal pain
• Upper respiratory tract infection

In rare instances, Poteligeo can cause more serious adverse reactions. These can include:

• Dermatologic toxicity – interrupt treatment for moderate or severe skin rashes. Discontinue treatment for life-threatening rash
• Infections
• Autoimmune complications
• Complications of allogeneic HSCT – monitor for severe acute graft-versus-host disease (GVHD) and steroid-refractory GVHD. Transplant-related mortality has occurred.

Your doctor will assess the benefits of using Poteligeo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Poteligeo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Poteligeo drug interactions

There is currently no data for Poteligeo interactions with other medications. However, other drugs may affect mogamulizumab, including prescription drugs and over-the-counter medicines, vitamins, and herbal products.

Poteligeo contraindications

You should not use Poteligeo if you:

• Are allergic to the active ingredient mogamulizumab
• Are allergic to any of the other ingredients in Poteligeo
• Are pregnant or are planning to become pregnant

Talk to your doctor before using Poteligeo if you:

• Are taking any of the medications that could interact with Poteligeo
• Have liver disease, including hepatitis B
• Have lung problems
• Have an autoimmune disorder – some people who already have an autoimmune disease may get worse during treatment
• Have had a stem-cell transplant from a donor
• Are breastfeeding or are planning to breastfeed

Poteligeo generic

Poteligeo is the trademark brand name for mogamulizumab marketed by Kyowa Kirin, Inc. A generic version of mogamulizumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Poteligeo savings through NiceRx.